Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00790530 · ClinicalTrials.gov registry record · NA
Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study
A NA study, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
NCT00790530 is a NA study that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 1,200 participants.
The verdict
NCT00790530, a NA study, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.
Interventions
- OTHER Usual Care
- BEHAVIORAL Automated Telephone Outreach with Speech Recognition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00790530
The ClinicalTrials.gov registry entry for NCT00790530 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00790530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00790530 about?
NCT00790530 is a clinical study titled "Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study". The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.
What is the current status of trial NCT00790530?
This trial is currently completed. It is a NA study. The enrollment target is 1,200 participants. The study started on 2006-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00790530?
The interventions under investigation include: Usual Care (OTHER), Automated Telephone Outreach with Speech Recognition (BEHAVIORAL).
Who is sponsoring clinical trial NCT00790530?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.